Pioneering biotechnology company that specializes in the development of advanced bioengineering solutions to address complex biological challenges
Raised to date
$1.1M
of $1.2M offered across 1 Form D filing
They are committed to driving innovation in the biotechnology sector through robust research and cutting-edge technology.
BioPhoundry stands out for its integration of synthetic biology with data-driven insights to optimize bioprocesses.
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Jan 29, 2025 | Equity | $1.1M/ $1.2M | Form D |
Biotechnology Platform
A state-of-the-art bioengineering platform that enables the design, testing, and optimization of biological systems with high precision and predictability.
Built for
Biotech and Pharmaceutical Companies
